Clinical trials
Phase 2 Leukemia, Myeloid, Acute trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias | 4 |
| Novartis Pharmaceuticals | 4 |
| PETHEMA Foundation | 3 |
| OncoVerity, Inc. | 2 |
| Ryvu Therapeutics SA | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Celgene | 1 |
| Cephalon | 1 |
| Cogent Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 30 |
| Leukemia | 8 |
| Myelodysplastic Syndromes | 8 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Leukemia, Myeloid | 2 |
| Myeloproliferative Disorders | 2 |
| Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Recurrence | 2 |
| Hematologic Diseases | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.